Tetralogy of Fallot (TOF) is a cyanotic congenital heart disease with four components including a significant non-restricted ventricular septal defect (VSD), overriding of the aorta, right ventricular outflow tract obstruction, and right ventricular hypertrophy (1). It accounts for 7 to 10 percent of all congenital heart defects. The etiology of the development of TOF in intrauterine life is multifactorial. Some of the risk factors include uncontrolled maternal diabetes, maternal exposure to retinoic acid, phenylketonuria, trisomy 21, trisomy 18, trisomy 13, and other chromosomal anomalies (7). Out of the 4 lesions, the degree of the right ventricular outflow tract obstruction(RVOTO) usually determines the degree of cyanosis and the severity of the symptoms (1). Depending on the degree of RVOTO it can be classified as 1) Pink TOF- with minimal or no RVOTO, 2) Blue TOF- classic with a degree of RVOTO, 3) Profound cyanosis TOF- severe or complete RVOTO.
The majority of the cases are diagnosed antenatally by fetal echocardiogram. An infant born with TOF may show a ‘Boot Shaped” heart on a chest X-ray. Electrocardiogram depicts right axis deviation (RAD) due to underlying right ventricular hypertrophy (RVH). Cardiac magnetic resonance imaging and catheterization can be useful but not routinely used (7). Most of the defects tend to persist including a VSD with TOF (8). The standard of care depends on the severity of the presentation. Severe RVOTO usually requires prostaglandin infusion to keep the ductus arteriosus open. Surgical corrections are usually late and involve a patch closure of the VSD, and repair of the RVOTO if any(9, 11).